COMP <GO>
DOCS vs NVDA // REVENUE GROWTH (YOY)
Doximity Inc. (NYSE) VS. NVIDIA Corporation (NASDAQ) • 15-METRIC TALLY: DOCS 6
— NVDA 9
▲ REVENUE GROWTH (YOY) LEADER: NVDA
LAST: $32.76 (-2.59%) • MKT CAP: $5.99B
revenue-growth
13.10%
LAST: $204.64 (-4.22%) • MKT CAP: $4.93T
revenue-growth
83.38%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DOCS VS. NVDA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DOCS | NVDA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 89.10% | 74.67% | +14.43 | DOCS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.20% | 65.06% | -47.86 | NVDA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 27.9x | 23.2x | +4.69 | NVDA | /valuation <GO> |
| Free Cash Flow Yield | 5.45% | 2.58% | +2.87 | DOCS | /fcf-yield <GO> |
| Operating Margin | 33.30% | 65.21% | -31.91 | NVDA | /operating-margins <GO> |
| Net Profit Margin | 30.40% | 63.66% | -33.26 | NVDA | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 13.10% | 83.38% | -70.28 | NVDA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.02% | -0.02 | NVDA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 22.31 | 19.52 | +2.79 | DOCS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 4/9 | +4.00 | DOCS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.80% | 9.01% | -1.21 | DOCS | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.7 | 35.1 | +26.61 | DOCS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.25 | 2.04 | -0.79 | NVDA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 25.7x | 17.0x | +8.68 | NVDA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.99B | $4.93T | -$4.93T | NVDA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DOCS REV | NVDA REV | DOCS GROSS % | NVDA GROSS % | DOCS FCF | NVDA FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $215.94B | — | 71.1% | — | $96.68B |
| FY 2025 | $644.9M | $130.50B | 89.1% | 75.0% | $326.5M | $60.85B |
| FY 2024 | $570.4M | $60.92B | 90.2% | 72.7% | $273.3M | $27.02B |
| FY 2023 | $475.4M | $26.97B | 44.0% | 56.9% | $162.7M | $3.81B |
| FY 2022 | — | $26.91B | — | 64.9% | — | $8.13B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DOCS // BETA 1.25
NVDA // BETA 2.04